Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin (Q57991308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

title

Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C S Palmer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

C Zhan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

A Elixhauser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

L Rance

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

B G Feagan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

T J Marrie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

250-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

Community-acquired pneumonia

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Community-acquired pneumonia: the annual cost to the National Health Service in the UK

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Evaluation of a pneumonia practice guideline in an interventional trial

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

The Clinical Benefit of In-Hospital Observation in ‘Low-risk’ Pneumonia Patients After Conversion From Parenteral to Oral Antimicrobial Therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)88483-0

7 January 2021

10.1016/S0149-2918(00)88483-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10743984 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference